Study on the comparison of postoperative liver injury caused by hepatic arterial perfusion chemotherapy combined with targeted immunotherapy with hepatic arterial chemoembolization combined with targeted immunotherapy for intermediate- and advanced-stage l  

作　　者：李榕 LI Rong(Hepatol Unit&Dept Infect Dis,Nanfang Hosp,South Med Univ,Guangzhou 510515)

机构地区：[1]Hepatol Unit&Dept Infect Dis,Nanfang Hosp,South Med Univ,Guangzhou 510515

出　　处：《China Medical Abstracts(Internal Medicine)》2024年第1期50-51,共2页中国医学文摘（内科学分册（英文版）

摘　　要：Objective To compare the postoperative liver function injury condition in patients with intermediateand advanced-stage hepatocellular carcinoma (HCC)treated with hepatic artery infusion chemotherapy(HAIC) and hepatic artery chemoembolization (TACE)combined with immune checkpoint inhibitors (ICIs) and multi-target tyrosine kinase inhibitors (TKIs).

关 键 词：HEPATIC CHEMOTHERAPY POSTOPERATIVE 

分 类 号：R735.7[医药卫生—肿瘤]